Kathy L Hibbs
CIK 1267487 · View on SEC EDGAR ↗
Insider
First SEC filing: March 18, 2026 · Latest: March 18, 2026
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 10 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 18, 2026 | LAB | A | 175,923 | — | — | 175,923 Direct | — | Acquired | (price as of 2026-08-21) |
| June 18, 2026 | LAB | A | 99,116 | — | — | 236,836 Direct | +71.97% | Acquired | (price as of 2026-08-21) |
| June 18, 2026 | SOPH | A | 28,818 | $5.46 | $157,346 | 218,569 Direct | +15.19% | Acquired | 52.0% (price as of 2026-08-21) |
| June 18, 2026 | SOPH | A | 19,724 | $5.46 | $107,693 | 109,492 Direct | +21.97% | Acquired | 52.0% (price as of 2026-08-21) |
| June 20, 2025 | LAB | A | 125,660 | — | — | 125,660 Direct | — | Acquired | (price as of 2026-08-21) |
| June 20, 2025 | LAB | A | 94,592 | — | — | 137,720 Direct | +219.33% | Acquired | (price as of 2026-08-21) |
| June 28, 2024 | LAB | A | 72,213 | — | — | 72,213 Direct | — | Acquired | (price as of 2026-08-21) |
| June 28, 2024 | LAB | A | 43,128 | — | — | 43,128 Direct | — | Acquired | (price as of 2026-08-21) |
| Jan. 5, 2024 | LAB | A | 205,794 | — | — | 205,794 Direct | — | Acquired | (price as of 2026-08-21) |
| Jan. 5, 2024 | LAB | A | 79,412 | — | — | 79,412 Direct | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 18, 2026 | LAB | Stock Option (Right to buy) | Common Stock (175,923) | $0.83 | June 18, 2036 | 175,923 | Acquired |
| June 18, 2026 | SOPH | Share Option (Right to Buy) | Ordinary Shares (28,818) | $5.46 | June 18, 2036 | 28,818 | Acquired |
| June 20, 2025 | LAB | Stock Option (Right to buy) | Common Stock (125,660) | $1.05 | June 20, 2035 | 125,660 | Acquired |
| June 28, 2024 | LAB | Stock Option (Right to buy) | Common Stock (72,213) | $1.77 | June 28, 2034 | 72,213 | Acquired |
| Jan. 5, 2024 | LAB | Stock Option (Right to buy) | Common Stock (205,794) | $2.47 | June 7, 2033 | 205,794 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.